NRD
CDMO

Nebula Research & Development’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Nebula Research & Development’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-45,008
Closed -$293K – 1035
2023
Q4 		$293K Buy
+45,008
New +$290K 0.09% 443

Other funds holding CDMO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Nebula Research & Development's CDMO Position: Q1 2024 in Review

Nebula Research & Development sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 45,008 shares — an estimated $293K sold.

Nebula Research & Development first reported a position in CDMO in Q4 2023 and held it in 1 quarter. The position peaked at $293K in Q4 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Nebula Research & Development reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nebula Research & Development sold 45,008 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $293K.
  • Nebula Research & Development first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Nebula Research & Development's Avid Bioservices, Inc. Common Stock position peaked at $293K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Nebula Research & Development's 13F filing for Q1 2024, filed 15 May 2024.